[Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products]

scientific article published on 01 June 2005

[Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products] is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TRACLI.2005.04.011
P698PubMed publication ID15894502

P2093author name stringPierre Bétrémieux
P Jego
Isabelle Grulois
H Gouëzec
Stanislas Nimubona
P2860cites workPlatelet transfusion trigger in difficult patientsQ33338491
Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task ForceQ33351618
Practice strategies for elective red blood cell transfusion. American College of PhysiciansQ67973950
P433issue2
P304page(s)169-176
P577publication date2005-06-01
P1433published inTransfusion Clinique et BiologiqueQ15758506
P1476title[Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products]
P478volume12

Reverse relations

cites work (P2860)
Q46971893Knowledge and attitudes of medical personnel in blood transfusion in Bamako, Mali
Q34638561Patient blood management in Europe
Q34988663Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period
Q35106170Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period
Q37209117Recommendations for the transfusion of plasma and platelets
Q36888740Spontaneous hematoma of right angle of the transverse mesocolon: exceptional complication of anticoagulant therapy with vitamin K
Q83808031[Techniques of preparation and indications of labile blood products]

Search more.